Mind Medicine (MindMed) (MMEDF) News Today $10.00 +0.15 (+1.52%) As of 08/11/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesBuy This Stock MMEDF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Mind Medicine upgraded at Oppenheimer on lead assetAugust 5, 2025 | msn.comMindMed outlines 2026 Phase III trial readouts and advances MM120 commercialization with new CFOJuly 31, 2025 | msn.comMindMed to Participate in June Investor ConferencesMay 28, 2025 | financialpost.comFMindMed to Participate in June Investor ConferencesMay 28, 2025 | financialpost.comFMind Medicine (MindMed) Inc. (MNMD): Analysts See 285% Upside PotentialMay 21, 2025 | insidermonkey.comWhy Mind Medicine Stock Vaulted More Than 8% Higher TodayMay 20, 2025 | fool.comWas Jim Cramer Right About Mind Medicine (MNMD) Stock?May 16, 2025 | insidermonkey.comMind Medicine (MindMed) Inc. (MMED.NE)May 8, 2025 | ca.finance.yahoo.comMind Medicine: Strong Data, But Psychedelic Stigma Still Clouds Investor ConfidenceApril 23, 2025 | seekingalpha.comMind Medicine: Initiating Hold Rating Due To Regulatory ChallengesApril 20, 2025 | seekingalpha.comPsychedelic: MindMed announces dosing in Phase 3 Emerge studyApril 17, 2025 | markets.businessinsider.comMindMed Appoints Matt Wiley as Chief Commercial OfficerMarch 17, 2025 | financialpost.comFMindMed Appoints Matt Wiley as Chief Commercial OfficerMarch 17, 2025 | financialpost.comFAnalysts Offer Insights on Healthcare Companies: Mind Medicine (MNMD), IGM Biosciences (IGMS) and ALX Oncology Holdings (ALXO)March 7, 2025 | markets.businessinsider.comMind Medicine's Net Losses Swell In Q4, But Retail Finds At Least 3 Reasons To Stay BullishMarch 7, 2025 | msn.comMind Medicine price target lowered to $16 from $27 at BairdMarch 7, 2025 | markets.businessinsider.comMind Medicine reports Q4 EPS (41c), consensus (28c)March 6, 2025 | markets.businessinsider.comMind Medicine (MindMed) Inc. (MNMD) Q4 2024 Earnings Call TranscriptMarch 6, 2025 | seekingalpha.comMindMed to Present at Leerink’s Global Healthcare Conference 2025March 4, 2025 | financialpost.comFMindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025February 20, 2025 | financialpost.comFMindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025February 20, 2025 | financialpost.comFMindMed doses first subject in Phase III Panorama study of GAD tabletFebruary 1, 2025 | msn.comMindMed launches phase 3 trial for anxiety treatmentJanuary 30, 2025 | msn.comEvercore ISI Group Initiates Coverage of Mind Medicine (MNMD) with Outperform RecommendationJanuary 28, 2025 | msn.comMind Medicine to be added to Nasdaq Biotechnology Index December 23.December 20, 2024 | markets.businessinsider.comMindMed to Be Added to the Nasdaq Biotechnology IndexDecember 19, 2024 | financialpost.comFMind Medicine (MNMD) Receives a Buy from OppenheimerDecember 18, 2024 | markets.businessinsider.comMindMed doses first subject in trial of tablets for generalised anxiety disorderDecember 17, 2024 | msn.comMindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 CongressDecember 11, 2024 | financialpost.comFMindMed call volume above normal and directionally bullishNovember 23, 2024 | markets.businessinsider.comRBC Capital Remains a Buy on Mind Medicine (MNMD)November 21, 2024 | markets.businessinsider.comMind Medicine price target raised to $16 from $14 at CanaccordNovember 9, 2024 | markets.businessinsider.comMind Medicine: A Strong Buy on Financial Health and Growth ProspectsOctober 11, 2024 | markets.businessinsider.comMind Medicine (MindMed) Inc. (MNMD) Q2 2024 Earnings Call TranscriptAugust 14, 2024 | seekingalpha.comPsychedelics Company MindMed Prices Public Offering Aiming To Raise $75MAugust 12, 2024 | msn.comPsychedelic Medicine Has a Therapy ProblemAugust 12, 2024 | msn.comMind Medicine Shares Drop 12% After Public Offering PricesAugust 9, 2024 | marketwatch.comBuy Rating Affirmed for Mind Medicine on Impressive MM120 Developments and Phase 3 Trial ProspectsJuly 31, 2024 | markets.businessinsider.comMind Medicine (MindMed) Inc. (MNMD)April 16, 2024 | finance.yahoo.comMind Medicine (NASDAQ:MNMD) is Leading the Surge in Psychedelic TherapiesMarch 27, 2024 | msn.comMind Medicine Inc Ordinary SharesMarch 22, 2024 | morningstar.comMMind Medicine Inc Ordinary Shares MMEDMarch 17, 2024 | morningstar.comMMind Medicine Stock (NASDAQ:MNMD) Dividends: History, Yield and DatesFebruary 22, 2024 | benzinga.comMMDCF Mind Medicine (MindMed) Inc. WT EXP 010724December 20, 2023 | seekingalpha.comWhat Makes Mind Medicine (MindMed) Inc. (MNMD) a New Buy StockDecember 20, 2023 | msn.comMind Medicine (MindMed) Inc. (MMCWF)December 12, 2023 | finance.yahoo.comMindMed to Host Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Business UpdateOctober 26, 2023 | financialpost.comFMindMed Inks $50M Credit Facility Deal With K2 HealthVentures For An Additional Operational YearAugust 15, 2023 | benzinga.comRBC Capital Maintains Mind Medicine (MNMD) Outperform RecommendationAugust 4, 2023 | msn.comThinking about buying stock in Mind Medicine (MindMed), OPKO Health, Grange Resources, Hyzon Motors, or Bright Minds Biosciences?July 18, 2023 | stockhouse.com Get Mind Medicine (MindMed) News Delivered to You Automatically Sign up to receive the latest news and ratings for MMEDF and its competitors with MarketBeat's FREE daily newsletter. Email Address MMEDF Media Mentions By Week MMEDF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MMEDF News Sentiment▼0.000.49▲Average Medical News Sentiment MMEDF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MMEDF Articles This Week▼00▲MMEDF Articles Average Week Get Mind Medicine (MindMed) News Delivered to You Automatically Sign up to receive the latest news and ratings for MMEDF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies 4Front Ventures News Today Ainos News Today Algernon Pharmaceuticals News Today Allstar Health Brands News Today AstraZeneca News Today AVAX Technologies News Today BriaCell Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:MMEDF) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredTurn your "dead money" into $306+ monthly (starting this month)Turn your "dead money" into $306+ monthly (starting this month) I've been tracking a financial revolution t...Investors Alley | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredBig Changes Coming in August — Is Your IRA Ready?Banks aren’t waiting for the headlines to catch up. They’ve already started moving their wealth out of pape...Reagan Gold Group | Sponsored#1 Pre-IPO Opportunity For 2025 [Take Action Now!]James Altucher has scored 37X and even 60X returns on past pre-IPO deals. But now he says a much bigger opport...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredSilver Demand Is Exploding—and Supply Can’t Keep UpElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mind Medicine (MindMed) Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mind Medicine (MindMed) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access